Immunohistochemical expression of p53, nm23-HI, Ki67 and DNA ploidy: Correlation with lymph node status and other clinical pathologic parameters in breast cancer

Citation
C. Midulla et al., Immunohistochemical expression of p53, nm23-HI, Ki67 and DNA ploidy: Correlation with lymph node status and other clinical pathologic parameters in breast cancer, ANTICANC R, 19(5B), 1999, pp. 4033-4037
Citations number
28
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
19
Issue
5B
Year of publication
1999
Pages
4033 - 4037
Database
ISI
SICI code
0250-7005(199909/10)19:5B<4033:IEOPNK>2.0.ZU;2-N
Abstract
Background: The different clinical evolution of breast cancer with similar pathological characteristics prompted the authors to investigate the progno stic significance of different biological markers. Methods: Seventy-one pri mary breast carcinoma specimens obtained by mastectomy or quadrantectomy we re examined for the determination of the p53, nm23 and Ki67 expression, wit h immunohistochemistry, and the DNA content, with static cytometry. Results : p53 protein was expressed as nuclear staining in 58% of the cases and was associated with high levels of Ki67, non-diploid lesions and lymph-node st atus. Positive staining for nm23 was significantly correlated only with his tologic grading. A predictive role in disease recurrence was demonstrated o nly in patients with a high Ki67 nuclear expression. Conclusions: From thes e data, we may conclude that, besides all the other traditional clinical mo rphological parameters, a pannel of different biological markers, such as K i67 and the determination of p53 expression, may be utilized to further cha racterize breast cancer and its biological behavior.